Preclinical and Clinical Advances of Targeted Protein Degradation as a Novel Cancer Therapeutic Strategy: An Oncologist Perspective
Year: 2020
Type: review
Source: Targeted Oncology
Institutions: Moffitt Cancer Center, University of South Florida
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3113562469
